ARCHIVES

Phase III Trial Would Give Clearer Picture Of C225 Role.

This article is from The Cancer Letter archive.

Vol. 28 No. 07 | February 15, 2002

Download PDF Visit The Full Archive

Related Articles

House committee asks GAO to investigate Klausner-era NCI contract with Harvard University.

September 9, 2005

DeVita Reshuffling NCI Office Space

April 18, 1980

Duke Comprehensive Cancer Center Wins Core Grant Renewal

September 17, 2010

SWOG Plans Increase in Payments to Centers for Trial Accrual.

May 25, 2007

Cobimetinib-Zelboraf Therapy Increases OS In BRAF V600 Mutation-Positive Disease

October 31, 2014

Clinical Trials Approved By NCI

September 26, 2003